Skip to content

5-Methoxy-N,N-dimethyltryptamine: spinal cord and brainstem mediation of excitatory effects on acoustic startle.

M Davis, D I Astrachan, P M Gendelman, D S Gendelman

Psychopharmacology 1980 DOI: 10.1007/BF00435302 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental study Peer reviewed
Population Rats
Interventions 5-methoxy-N N-dimethyltryptamine (5-MeODMT)
Dose 0.03, 0.06, 0.12, 0.25, 1.0, 2.0, 4.0, and 8.0 mg/kg body weight
Topics 5-MeO-DMT DMT
Citations 39
Key findings 5-MeODMT increased the acoustic startle reflex in rats in a dose-dependent manner starting at 0.12 mg/kg, an effect that originates in the spinal cord and is blocked by certain serotonin antagonists.

Abstract

The effects of different doses (0.03, 0.06, 0.12, 0.25, 1.0, 2.0, 4.0, and 8.0 mg/kg body weight) of 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) were tested on the acoustic startle reflex in rats. Beginning at 0.12 mg/kg, 5-MeODMT increased startle monotonically up to the highest dose used. 5-MeODMT still increased startle in acutely decerebrate rats or when infused directly onto the spinal cord. The excitatory effects of a high systemic dose of 5-MeODMT were completely blocked by cinanserin, cyproheptadine, and propranolol, but not by parachlorophenylalanine, alpha-methyl-p-tyrosine, haloperidol, sotalol, or phenoxybenzamine. The results were discussed in terms of a new theory, which suggests that stimulation of serotonin receptors in the spinal cord enhance startle whereas serotonin receptors in the forebrain inhibit startle.

Comparable studies

Other preclinical and animal studies on 5-MeO-DMT, most cited first.

Citations in the library

Explore topics